Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:05 pm Purchase | 2024-09-30 | 13G | Klaviyo, Inc. KVYO | Sands Capital Ventures LLC | 4,943,495 6.800% | 767,468 (+18.38%) | Filing History |
| 2024-02-13 3:41 pm Purchase | 2023-12-31 | 13G | Klaviyo, Inc. KVYO | Sands Capital Ventures LLC | 4,176,027 9.500% | 4,176,027 (New Position) | Filing History |
| 2024-02-13 3:40 pm Sale | 2023-12-31 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | Sands Capital Ventures LLC | 1,652,605 7.400% | -1 (-0.00%) | Filing History |
| 2023-02-14 3:26 pm Purchase | 2022-12-31 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | Sands Capital Ventures LLC | 1,652,606 7.900% | 1,652,606 (New Position) | Filing History |
| 2023-02-14 3:25 pm Purchase | 2022-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS | Sands Capital Ventures LLC | 3,417,075 8.300% | 3,417,075 (New Position) | Filing History |